Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Genomic Valley Biotech Ltd ("Target Company").

(SEBI Registered Category I Merchant Banker) Date: November 03,2026 The Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001 Ref.: Genomic valley Biotech Limited (scrip Code: sggzoil) Dear Sir/Madam, SUBJECT: OPEN OFFER FoR ACeUISITION oF uplo 7,94,170 Eeurry SHARES FROM THE SHAREHOLDERS OF GENOMIC VALLEY BIOTECH LIMITED (HEREIN AFIER REFERRED TO AS "GVBL"/ 'TARGET COMPANY'7 "TARGET') BY MR. PANKAI GROVER AND MR. ABHISEK GUPTA (HEREINAFTER REFERRED TO AS "ACQUIRERS") we are pleased to submit Copy of Draft Letter of offer (,,DLOF,,) dated November 03, 2026, putsuant to and in compliance with applicable provisions of the Securities and Exchange Board of India (Substantial Aiquisition of Shares and Takeovers) Regulations,2011. Kindly take the above information on your recorcls and disseminate the DLOF on the website of BSE Limired. Thanking You, Yours faithfully For Fintell te Advisors Private Limited DIN:09081387 FINTELLECTUAL CORPORATE ADVISORS PRIVATE LIMITED Reg. Office: S-15, First Floor, Sapient House, Okhla lndustrial Area phase-ll, New Delhi-110 020 llN: U74999D1202 1 PTC3777 48 corporate office: B-20, second Floor, sector-1, Noida, Uttar pradesh-201 301 @ info@fi ntellectualadvisors.com valuations@fi ntellectualadvisors.com @ www.fintellectualadvisors.com $ fel: +91-l2O-42G6OgO DRAFT LETTER OF OFFER THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION The Letter of Offer will be sent to you as a Public Shareholder(s) of Genomic Valley Biotech Limited (hereinafter referred to as “GVBL” or “Target Company” or "Target"). If you require any clarifications about the action to be taken, you may consult your Stock Broker or Investment Consultant or Manager/Registrar to the Offer. In case you have recently sold your shares in the Company, please hand over the Letter of Offer and the accompanying Form of Acceptance cum Acknowledgement and Transfer Deed to the Member of Stock Exchange through whom the said sale was effected. Open Offer by Mr. Pankaj Grover (“Acquirer 1”) Address: 207-B, 2nd Floor, I-Block, Near Water Tank, South City-II, Gurgaon, Haryana-122018 Tel. No.: 9818199009; Email Id: pankaj.grover@shivaturned.com Mr. Abhisek Gupta (“Acquirer 2”) Address: Flat No.-11164, Ats Advantage, Ahinsa Khand -1, Indirapuram, Sahibabad, Ghaziabad, Uttar Pradesh-201010 Tel. No.: 9818226757; Email Id: abhi83gpt@gmail.com to the shareholder(s) of GENOMIC VALLEY BIOTECH LIMITED Registered office: 4 K.M. Stone, Berri Chharra Road, Village Kherka, Musalman, P.O. Tandaheri, Teh Bahadu, Jhajjar, Haryana-124507; Corporate office: G-74, Pushkar Enclave, Paschim Vihar, Delhi-110063; Telephone No.: 9811341542; Email Id: genomicvalley@gmail.com; Website: www.genomicvalley.com; To acquire upto 7,94,170 (Seven Lakh Ninety Four Thousand One Hundred Seventy) Fully Paid up Equity Shares of face value of ₹10 each ("Offer Shares"), representing in aggregate 26% of the voting share capital of the Target Company at a price of ₹ 30/- (Rupees Thirty Only) (“Offer price”) per fully paid up Equity Share, payable in cash. Please Note: 1. This Offer is being made by the Acquirers pursuant to regulation 3(1) and regulation 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto (“SEBI (SAST) Regulations”). 2. This Open Offer is not conditional upon any minimum level of acceptance in terms of regulation 19 of SEBI (SAST) Regulations. 3. This Open Offer is not a competing offer in terms of regulation 20 of the SEBI (SAST) Regulations. There has been no Competing Offer as on the date of this Draft Letter of Offer. 4. As on the date of this Draft Letter of Offer, there are no statutory approvals required for the purpose of implementing this Offer. If any statutory approvals become applicable prior to the completion of the Offer, the Offer would also be subject to receipt of such statutory approvals. 5. If there is any upward revision in the Offer Price/Offer Size by the Acquirers at any time up to 1 (One) Working Day prior to the commencement of the Tendering Period i.e. up to Thursday, December 10, 2026, or in the case of withdrawal of offer, the same would be informed by way of the Public Announcement in the same newspapers where the original Detailed Public Statement has appeared. Such revision in the Offer Price would be payable by the Acquirers for all the Offer Shares validly tendered anytime during the Tendering Period of the Open Offer. 6. A copy of the Public Announcement, the Detailed Public Statement, Draft Letter of Offer and Letter of Offer (including Form of Acceptance cum Acknowledgment) are also available on SEBI’s website at www.sebi.gov.in. MANAGER TO THE OFFER REGISTRAR TO THE OFFER FINTELLECTUAL CORPORATE ADVISORS PRIVATE LIMITED SKYLINE FINANCIAL SERVICES PRIVATE LIMITED SEBI Registration No.: INM000012944 SEBI Registration No.: INR000003241 Corp. Off.: B- 20, Second Floor, Sector -1, Noida, Regd. Off.: D-153 A, 1st Floor, Okhla Industrial Area, Uttar Pradesh- 201301 Phase-I, New Delhi-110020 Tel. No.: +91-120-4266080 Tel No.: 011-40450193-97 Contact Person: Mr. Amit Puri Contact Person: Mr. Anuj Kumar E-mail: info@fintellectualadvisors.com Email id.: ipo@skylinerta.com Website: www.fintellectualadvisors.com Website: www.skylinerta.com Offer Opening Date Offer Closing Date SCHEDULE OF THE ACTIVITIES PERTAINING TO THE OFFER Tentative Schedule of Activities Day and Date* Date of the Public Announcement Monday, October 19, 2026 Last date of publication of the Detailed Public Statement Tuesday, October 27, 2026 Last date of filing of the Draft Letter of Offer with SEBI Tuesday, November 03, 2026 Last date for a Competing Offer Wednesday, November 18, 2026 Last date for receipt of comments from SEBI on Draft Letter of Offer (in the event SEBI has Thursday, November 26, 2026 not sought clarifications or additional information from the Manager to the Open Offer) Identified Date# Monday, November 30, 2026 Last date by which Letter of Offer will be dispatched to the Shareholders Monday, December 07, 2026 Last date by which an independent committee of the Board of Target Company shall give its Wednesday, December 09, 2026 recommendation Last date for revising the Offer Price/ Offer Size Thursday, December 10, 2026 Advertisement of Schedule of Activities for Open Offer, status of statutory and other Friday, December 11, 2026 approvals in newspaper (Offer Opening Public Announcement Date) Date of commencement of tendering period (Offer Opening Date) Monday, December 14, 2026 Date of expiry of tendering period (Offer Closing Date) Monday, December 28, 2026 Date by which all requirements including payment of consideration would be completed Monday, January 11, 2027 Notes: *The above timelines are indicative (prepared on the basis of timelines provided under the SEBI (SAST) Regulations) and are subject to receipt of relevant approvals from various statutory/regulatory authorities and may have to be revised accordingly throughout this document. #Identified Date is only for the purpose of determining the names of the shareholders as on such date to whom the Letter of Offer would be sent. All owners (registered or unregistered) of Equity Shares of the Target Company (except (a) the Promoter and Promoter Group of the Target Company; (b) the Acquirers and any person deemed to be acting in concert with them; (c) the parties to the Share Purchase Agreement; (d) any person deemed to be acting in concert with the parties to SPA) are eligible to participate in the Offer at any time before the closure of the Offer. RISK FACTORS RISKS RELATED TO THE TRANSACTION, THE PROPOSED OPEN OFFER AND THE PROBABLE RISKS INVOLVED IN ASSOCIATING WITH THE ACQUIRERS (A) Risk relating to the transaction The Open Offer is subject to compliance with terms and conditions as set out under the Share Purchase Agreement dated Monday, October 19, 2026. As on the date of this Draft [Showing first 8,000 characters — download PDF for full document]